Abstract:Background:The present study aimed to investigate the effects of Bay 60-7550, a selective phosphodiesterase-2A(PDE2A) inhibitor, on mechanical pain threshold and its potential mechanism in the neuropathic pain(spinal cord injury-neuropathic pain, SCI-NP) models of rats after spinal cord injury (SCI).Methods: Male SD rats were randomly divided into four groups: the Sham group, SCI group, SCI+Vehicle group and SCI+Bay 60-7550 group. The mechanical pain thresholds were evaluated by the von Frey test from the day before surgery until the 21th postoperative day. PDE2A expression levels in spinal cord were measured by immunohistochemistry. The proportions of M1/M2 microglia/macrophages polarization were assessed by flow cytometry and qRT-PCR. The expressions of microglia/macrophages and their downstream biomarkers (CD86、CD163、IL-6、IL-1β、IL-10、TGF-β) were measured by qRT-PCR. Results: Intrathecal administration of Bay 60-7550, significantly attenuated mechanical allodynia in rats after SCI. Compared with the sham group, PDE2A expression was dramatically elevated in the spinal dorsal horn of rats after SCI(P<0.01). Furthermore, the overexpression of PDE2A was inhibited by Bay 60-7550 treatment. Bay60-7550 delivery reduced pro-inflammatory factors (IL-6, IL-1β) expression(P<0.01, P<0.05), increased anti-inflammatory factors (IL-10, TGF-β) expression in the spinal cord significantly(P<0.05). Consistently, Bay60-7550 treatment promoted the proportion of M2-type microglia/macrophages while decreased the proportion of M1-type microglia/macrophages in rats after SCI. Conclusion: Inhibiting the overexpression of PDE2A might attenuate the development of NP in rats after SCI, and the mechanism might be related to the regulation of microglia/macrophages polarization.